Public market data

CL Price Chart

Colgate-Palmolive Company

CL news

Source: Zacks Investment Research

Procter & Gamble raised its fiscal 2027 all-in sales growth guidance to 2-4% following the completion of the Thorne acquisition, but maintained unchanged organic sales growth at 1-3% and core earnings growth at 0-3%. The company faces headwinds from $300 million in higher financing costs, $1.4 billion in commodity pressures, and $2 billion in restructuring costs, which limit the acquisition's near-term earnings contribution.

Source: Zacks Investment Research

Procter & Gamble reported strong fiscal Q1 organic sales growth of 4%, driven by volume gains and broad-based growth across all product categories and regions. However, the company's premium valuation (23.81X forward earnings), rising commodity and energy costs ($1.4B headwind expected in fiscal 2027), and modest full-year earnings guidance of 0-3% growth limit near-term upside potential. Strong cash flow supports dividends and buybacks, but the investment case remains balanced.

Source: Zacks Investment Research

Procter & Gamble (PG) shares gained 17.4% over three months, driven by broad-based 4% organic sales growth across all product categories and regions. However, rising input costs, margin pressures, and a premium valuation of 23.81X forward earnings raise concerns about sustainability. While productivity savings and innovation in key segments like Fabric Care and Beauty support the rally, weakness in Health Care and Grooming segments, along with $1.4 billion in expected cost pressures for fiscal 2027, temper the outlook.

Source: Zacks Investment Research

Procter & Gamble's Health Care segment is sustaining growth through innovation and portfolio expansion, with organic sales rising 4% in Q1 fiscal 2027. The company faces affordability pressures on premium brands but balances this with value offerings. A potential recovery in cold and cough season demand and the Thorne acquisition could provide additional growth catalysts. Competitors Church & Dwight and Colgate-Palmolive are also leveraging innovation and strong portfolios to drive health care growth.

Source: The Motley Fool

Colgate-Palmolive and Kimberly-Clark are both Dividend Kings with strong track records, but they differ in valuation and growth strategy. Colgate-Palmolive trades at a premium (24.3x forward P/E) with growth driven by its Hill's Pet Nutrition segment, while Kimberly-Clark offers a lower valuation (14.7x forward P/E) but faces integration challenges from its Kenvue acquisition. The choice depends on whether investors believe in Colgate's pet food expansion or Kimberly-Clark's expanded hygiene portfolio.

Source: Zacks Investment Research

The Consumer Products-Staples industry faces significant headwinds from elevated cost pressures, consumer price sensitivity, and currency fluctuations. Despite these challenges, four key companies are leveraging operational efficiencies and strategic initiatives to navigate the difficult environment. The industry carries a Zacks Industry Rank #194 (bottom 21%), reflecting negative earnings outlooks, though it has outperformed the S&P 500 over the past year.

Source: Zacks Investment Research

In a comparison of two Consumer Products - Staples sector stocks, BJ's Wholesale Club emerges as the better value opportunity. BJ holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 23.54 and PEG ratio of 3.25. Colgate-Palmolive has a Zacks Rank #3 (Hold) with a Value grade of D, showing a forward P/E of 25.02 and PEG ratio of 4.44. BJ's stronger earnings estimate revisions and more attractive valuation metrics make it the superior choice for value investors.

Source: Zacks Investment Research

The Consumer Products-Staples industry is navigating a challenging environment marked by elevated raw material, labor, and transportation costs, alongside heightened consumer price sensitivity and spending volatility. Companies are pursuing cost optimization, digital investments, and portfolio optimization strategies. The industry carries a Zacks Industry Rank #194 (bottom 21%), reflecting negative earnings outliers, though it has outperformed the S&P 500 over the past year with a 10.4% gain.

Source: The Motley Fool

Five Dividend King stocks—Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Colgate-Palmolive—have each increased dividends for at least 50 consecutive years. These recession-resistant companies from consumer staples and healthcare sectors offer reliable income streams and resilience during market volatility, making them attractive for investors seeking stability.

Source: The Motley Fool

The article discusses a long-term investment strategy for building a 'forever portfolio' with stocks suitable for buy-and-hold investors. It emphasizes the importance of adopting a different mindset when investing for longer time horizons, though the specific stock recommendations are behind a paywall.

Source: Zacks Investment Research

Procter & Gamble's Beauty segment achieved 5% organic sales growth in Q1 FY27, driven by product innovation and stronger brand execution across Hair Care and Skin & Personal Care. Pantene gained U.S. market share while SK-II posted double-digit growth in Greater China. PG maintains its fiscal 2027 organic sales growth outlook of 1-3%, with management seeing further acceleration opportunities through innovation and retail execution.

Source: The Motley Fool

The article compares Colgate-Palmolive, a defensive consumer staple with $21B in TTM revenue and a 2.19% dividend yield, against Chipotle Mexican Grill, a growth-focused fast-casual restaurant chain with $12.7B in TTM revenue. Despite Colgate's higher market cap and stable cash flows, the author recommends Chipotle for 2027, citing potential sector rotation away from tech, strong momentum from new menu innovations, and multiple growth catalysts including national catering expansion and international growth.

Source: The Motley Fool

Kraft Heinz is selling its North American coffee business to One Rock Capital Partners for $500 million in net proceeds to pay down debt. The move signals financial strain, as the company's earnings have declined and its dividend payout ratio is high relative to earnings. With diluted per-share profit of $0.46 last quarter versus a quarterly dividend of $0.40, there is minimal buffer, raising concerns about the sustainability of the dividend and the possibility of a future dividend cut.

Source: The Motley Fool

In comparing two consumer staples stocks during market turmoil, Colgate-Palmolive emerges as the better defensive choice over Kraft Heinz. While Kraft Heinz offers a higher dividend yield of 6.5%, Colgate-Palmolive demonstrates superior fundamentals with consistent revenue growth (4.6% in Q3), a 63-year dividend increase streak (Dividend King status), and a healthy 10.5% net margin. Kraft Heinz faces challenges with declining sales (-2% in Q3), a -23.4% net margin, and ongoing portfolio restructuring, despite trading at a lower valuation multiple.

Source: The Motley Fool

The article compares two defensive consumer goods stocks for 2027 investment. Both Colgate-Palmolive and Hershey show similar 6% revenue growth, but Hershey is recommended as the better buy due to its lower valuation (19.1x forward P/E vs. 24.6x), higher dividend yield (3.4% vs. 2.2%), and attractive pricing following cocoa cost pressures. Colgate offers global stability through oral care and pet nutrition, while Hershey benefits from resilient American snacking demand.

Company profile

Colgate-Palmolive Company logo

Colgate-Palmolive Company

Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.

Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Listed
Jan 9, 1951
Exchange
XNYS

300 PARK AVE, NEW YORK, NY, 10022

Equivalent futures contracts

Follow the Crude Oil WTI market hub or open a listed contract directly.

Knowledge graph

Frequently asked questions

What is CL?
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants,...
How do I follow CL price alerts?
Create a free Arc Research account, open the CL chart, and follow the ticker to get alerts and keep exploring beyond the three-chart guest preview.
Does Arc Research show historical CL prices?
Yes. The public CL page includes an interactive candlestick chart with volume and optional moving averages so you can review recent price history.
What industry is Colgate-Palmolive Company in?
Colgate-Palmolive Company is classified under PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS.

Arc Research publishes market data and research for information only. It is not investment, trading or financial advice, and Arc Research is not a registered investment adviser or commodity trading advisor. Futures and options trading carries a substantial risk of loss. Hypothetical, backtested and paper results are not actual trading. Read the full disclaimer · Terms of Service · Affiliates